上海复星医药(集团)股份有限公司
Shanghai Fosun Pharmaceutical Group Co LtdCNCNYShanghai Fosun Pharmaceutical Group Co Ltd (HK:2196) — Drug Manufacturers - Specialty & Generic. Število borz, na katerih se trgujejo delnice družbe: 3. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.
O podjetju
- Spletna stran
- fosunpharma.com
- Sektor
- Healthcare · Drug Manufacturers - Specialty & Generic
- Sedež
- Shanghai, China
- Izvršni direktor
- Yi Liu
- Zaposleni
- 40 684
- Ustanovljena
- 1994
- Na borzi od
- 30.10.2012 (HK:2196)
- Delnice v obtoku
- Prosto prenosljive delnice
- 1.63 mrd.
- Tržna kapitalizacija
- 9.46 mrd. HKD
- Notranje osebe
- 43.02%
- Institucionalni vlagatelji
- 8.48%
- ISIN
- CNE100001M79
- Delež izplačila
- 54.2%
- FCF
- 885 mio. CNY213%
- Dolg
- 39.5 mrd. CNY18 let FCF
- Dividendni staž
- 25 let
- Dobički, FCF in izplačane dividende — za 12 mesecev do 31.03.2026 (najnovejše poročilo podjetja).
Opis
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Dividende
Shanghai Fosun Pharmaceutical Group Co Ltd (2196) izplačuje dividende enkrat letno. V zadnjih 12 mesecih je bilo plačanih 0.45 HKD na delnico (plačila: 1). To je približno 2.52% trenutne cene delnice. Leta neprekinjenih dividend: 25.
| Ex-datum | Izplačilo | Znesek | % | Vrsta | Oznaka |
|---|---|---|---|---|---|
| 2026-07-16 | — | 0.4500 HKD | 2.5/2.5 % | letno | HK:2196 |
| 2025-07-24 | — | 0.3500 HKD | 2.0/2.0 % | letno | HK:2196 |
| 2024-07-26 | — | 0.3000 HKD | 1.7/1.7 % | letno | HK:2196 |
| 2023-07-31 | — | 0.4600 HKD | 2.6/2.6 % | letno | HK:2196 |
| 2022-06-08 | — | 0.6600 HKD | 3.7/3.7 % | letno | HK:2196 |
Novice ta teden
Novic s spletnega mesta podjetja še ni.
Največji imetniki
| Imetnik | Delež | Delnice | Datum poročila |
|---|---|---|---|
| Wu (Yi Fang) (Director) | ≈0.04% | 1.06 mio. | 2018-12-31 |
